nominally significantp = .02
Differences in convulsive seizure reduction between placebo and CBD emerged during titration and became nominally significant by Day 12 for CBD20 ( p = .02) and Day 13 for CBD10 ( p = .03).
Differences in convulsive seizure reduction between placebo and CBD emerged during titration and became nominally significant by Day 12 for CBD20 ( p = .02) and Day 13 for CBD10 ( p = .03).